SMOFlipid
Sponsors
Medical University of Vienna, Mansoura University, Baylor College of Medicine, Centre Hospitalier Universitaire de Nice, Centro Hospitalar de Lisboa Central
Conditions
CholestasisCovid19Crohn DiseaseDietary and Nutritional TherapiesEnd-stage Liver DiseaseGrowth FailureHome Parenteral NutritionIntestinal Fistula
Phase 1
Phase 3
Phase 4
Preventing Cholestasis Using SMOFLipid®
CompletedNCT01585935
Start: 2012-06-30End: 2017-11-13Updated: 2018-01-09
Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population
CompletedNCT02539316
Start: 2015-06-30End: 2016-10-31Updated: 2017-04-13
Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions
TerminatedNCT02633384
Start: 2011-08-31End: 2017-04-30Updated: 2017-07-13
SMOFLipid in Patients Who Are Intralipid Intolerant
WithdrawnNCT03054948
Start: 2017-02-01End: 2018-03-20Updated: 2018-03-22
Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
TerminatedNCT03563222
Start: 2019-12-18End: 2022-07-08Updated: 2022-12-12
Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants
NCT04277923
Start: 2020-02-29End: 2021-08-31Target: 66Updated: 2020-02-20
Unknown Phase
Omega 3 Lipid Emulsions and Liver Transplantation
NCT01957943
Start: 2014-05-31End: 2018-03-31Target: 114Updated: 2017-03-28
SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
NCT02412566
Updated: 2025-08-19
Intralipid Versus SMOFlipid in HPN Patients
CompletedNCT03773237
Start: 2018-12-31End: 2024-10-01Updated: 2025-05-16
Supplements SMOF in TPN for Liver Transplantation Recipients
CompletedNCT04572373
Start: 2012-01-01End: 2015-06-30Updated: 2020-10-08
Lipid Emulsion in Cardiac Valve Replacement Surgery
NCT04951791
Start: 2021-08-31End: 2023-10-31Target: 68Updated: 2021-07-07